DSG3 and acquired polycythemia vera: The repertoire of mAbs targeting the EC2A epitope at pre-onset was broader than the limited VH4-39 and VH1-2 gene usage that was detected at diagnosis, again suggesting that a small number of MBCs are being actively selected in response to Dsg3 and driving PV pathogenesis.